Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
11/2010
11/11/2010US20100286170 (3-hydroxy-4-amino-butan-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treating
11/11/2010US20100286146 Carboxamide compounds and their use as calpain inhibitors
11/11/2010US20100286144 Heteroaryl derivatives
11/11/2010US20100286112 Compounds for the treatment of metabolic disorders
11/11/2010US20100286109 Amide derivatives as positive allosteric modulators and methods of use thereof
11/11/2010US20100286073 Compounds and methods for pharmaceutical use
11/11/2010US20100282081 Absorbent liquid, and apparatus and method for removing c02 or h2s from gas with use of absorbent liquid
11/11/2010CA2799157A1 Ammo acid derivatives for the treatment of neuropathic pain
11/11/2010CA2761241A1 Tetracycline compounds
11/11/2010CA2760464A1 Carboxamide compounds and their use as calpain inhibitors
11/11/2010CA2759592A1 Insecticidal compounds
11/11/2010CA2758302A1 Compounds and compositions comprising cdk inhibitors and methods for treatment of cancer
11/10/2010EP2247569A1 Acid salt of tolterodine having effective stability for transdermal drug delivery system
11/10/2010EP1947083B1 Process for production of aralkyloxypyrrolidine derivative
11/10/2010EP1513589B1 1,5-disubstituted pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma
11/10/2010EP1181274B1 Iminocyclitol inhibitors of hexoaminidase and glycosidase
11/10/2010CN1980889B Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
11/10/2010CN101880256A Method for preparing panipenem side chain
11/10/2010CN101880255A Method for preparing panipenem side chain
11/10/2010CN101880227A Process for the preparation of intermediates useful in the synthesis of statin derivatives, and intermediates thereof
11/10/2010CN101318922B Novel dipeptidyl peptidase restrainer, synthesizing process and uses thereof
11/10/2010CN101092385B Method for preparing unformed Atorvastatin calcium by using crystalline Atorvastatin sodium
11/09/2010US7829728 2-[(S)-1-(9-{Benzyl-1,2-(8-benzyloxy-2-oxo-1,2-dihydroquinolin-5-yl)-2-oxoethyl]-amino}nonyl)pyrrolidin-3-yl -2,2-diphenylacetamide; beta 2 adrenergic receptor agonist, muscarinic receptor antagonist activity; chronic obstructive pulmonary disease and asthma
11/09/2010US7829597 preventing the formation of insoluble A beta and arresting the production of A beta; beta-site amyloid precursor protein-cleaving enzyme; 3-[(2-amino-2-methyl-3-phenylpropoxy)methyl]-N-[(1R)-1-(4-fluorophenyl)ethyl]-[methyl(methylsulfonyl)amino]benzamide
11/09/2010US7829571 monocyte chemotactic protein antagonists such as -(3S)-1-(4-(tert-butylamino)cyclohexyl)-3-(6-(trifluoromethyl)quinazolin-4-ylamino)pyrrolidin-2-one, used for the treatment of asthma, multiple sclerosis, arteriosclerosis and rheumatoid arthritis
11/09/2010CA2520297C Mass labels
11/09/2010CA2434937C Phenyl derivatives
11/09/2010CA2434028C Amino ceramide-like compounds and therapeutic methods of use
11/04/2010WO2010126820A2 Preparation of alkyl esters of n-protected oxo-azacycloalkylcarboxylic acids
11/04/2010WO2010126102A1 Scca-1 production inhibitor having a carboxamide derivative and/or a salt thereof as an active ingredient
11/04/2010WO2010125578A2 A process for the preparation of lasofoxifene tartrate
11/04/2010WO2010124845A1 Pesticidal arylpyrrolidines
11/04/2010WO2010124521A1 Derivatives of rhein, preparation methods and uses thereof
11/04/2010US20100280412 Anticoagulation Of Human Blood Ex Vivo
11/04/2010US20100280259 N-Tert-Butoxycarbonyl-2-Pyrrolidinones and Production Method Thereof
11/04/2010US20100280252 Poly(ethylene glycol) containing chemically disparate endgroups
11/04/2010US20100280248 Novel compounds that are useful for improving pharmacokinetics
11/04/2010US20100280034 Modulation of pathogenicity
11/04/2010US20100280024 Renin inhibitors
11/04/2010US20100280018 Derivatives Of Hydroxamic Acid As Metalloproteinase Inhibitors
11/04/2010US20100279998 Piperidinylalkylcarbamate derivatives, methods for their preparation and the therapeutic use thereof as fatty acid amido hydrolase enzyme inhibitors
11/04/2010US20100279997 Analgesic that binds filamin a
11/04/2010US20100276638 Functionalized matrixes for dispersion of nanostructures
11/03/2010EP2245009A2 Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
11/03/2010EP2245008A1 Method for the preparation of atorvastatin and intermediates used therein
11/03/2010EP2245007A1 Novel crystalline forms
11/03/2010EP2245006A1 Sulfonamides as orexin antagonists
11/03/2010EP1863477B1 3,4-substituted pyrrolidine derivatives for the treatment of hypertension
11/03/2010EP1496838B1 Substituted amides
11/03/2010CN1845925B Substituted heterocycles
11/03/2010CN101878199A 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis
11/03/2010CN101878198A Phenylpyrrolidine compounds
11/03/2010CN101875654A Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative
11/03/2010CN101875626A Method for synthesizing N-benzyl maleimide from immobilized supported acid catalyst
11/03/2010CN101875625A Recrystallization method for improving trans-fluorochloridone content
11/03/2010CN101875624A Preparation method of 1-tert-butyloxycarbonyl-3-cyano-4-oxo-pyrrolidine
11/02/2010US7825268 Alkoxylactones, alkoxylactams and alkoxythiolactams for controlling processes based on microbial interaction
11/02/2010US7825193 Dithiocarbamic esters
11/02/2010US7825152 Organic compounds and their uses
11/02/2010US7824710 slurrying salt formation, crystallization
11/02/2010CA2389681C Npy y5 antagonist
10/2010
10/28/2010WO2010123139A1 Arylcarboxamide derivative having sulfamoyl group
10/28/2010WO2010123016A1 Carboxylic acid compound
10/28/2010WO2010123006A1 Pyrrolidine compound
10/28/2010WO2010122968A1 Diacylethylenediamine compound
10/28/2010WO2010121918A1 Proline derivatives as cathepsin inhibitors
10/28/2010US20100274051 Inflammatory cytokine release inhibitor
10/28/2010US20100274027 Organic compounds
10/28/2010US20100274025 Methods and compounds for producing dipeptidyl peptidase iv inhibitors and intermediates thereof
10/28/2010US20100273739 Aminotetraline Derivatives, Pharmaceutical Composition, Containing Them, and Their Use in Therapy
10/28/2010US20100273724 Pegylated ion channel modulating compounds
10/28/2010CA2759690A1 Carboxylic acid compound
10/28/2010CA2759264A1 Diacylethylenediamine compound
10/28/2010CA2758210A1 Proline derivatives as cathepsin inhibitors
10/27/2010EP2243539A2 Functionalized ionic liquids, and methods of use thereof
10/27/2010EP2242872A1 Corrosion inhibitors having increased biological degradability and minimized toxicity
10/27/2010EP2242739A1 Insecticidal arylpyrrolines
10/27/2010CN101870671A Adamantly pyrrolidine derivative, and preparation and application thereof
10/27/2010CN101200445B Compound containing bispyrrolidones as well as synthetic method and uses thereof
10/26/2010US7820846 by phosgenation of an aminobenzoylsulfamic acid amide intermediate; prepared from a p-nitrobenzoyl chloride or benzoate and a sulfamic acid amide and reducing the nitrobenzoylsulfamic acid amide; isocyanates are crop protection agents
10/26/2010US7820831 Compounds comprising a thiocarbonyl-sulfanyl group which can be used for the radical synthesis of α-perfluoroalkylamine compounds
10/26/2010US7820825 N-substituted-azacyclylamines as histamine-3 antagonists
10/26/2010US7820712 Uses of ion channel modulating compounds
10/26/2010US7820702 Sulfonylpyrrolidine modulators of androgen receptor function and method
10/26/2010US7820661 prostaglandin EP2 receptor agonists for treating baldness, glaucoma, post-surgical and post-laser trabeculectomy ocular hypertensive episodes, inflammatory bowel disease, and as presurgical adjuncts
10/26/2010US7820641 Bactericides; antitumor agents; moderators of gene expression; viricides; parasiticides; malaria therapy
10/26/2010CA2449192C Novel nitriles useful as reversible inhibitors of cysteine proteases
10/21/2010WO2010120935A1 Anti-viral compounds
10/21/2010WO2010120910A1 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
10/21/2010WO2010119992A1 Derivatives of n-acyl-n'-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
10/21/2010WO2010119848A1 Novel method for producing optically active pyrrolidine compound
10/21/2010WO2010119222A1 Derivatives of n-[(7-aza-bicyclo[2.2.1]hept-1-yl)-aryl-methyl]-benzamide, preparation thereof, and therapeutic use thereof
10/21/2010WO2010075103A3 A lubricating oil additive composition and method of making the same
10/21/2010WO2009122445A3 Donor- acceptor fluorene scaffolds : a process and uses thereof
10/21/2010US20100267966 Optically active 3-aminopyrrolidine salt, process for production thereof, and method for optical resolution of 3-aminopyrrolidine
10/21/2010US20100267965 3-Alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one Derivatives as Intermediates in the Synthesis of Renin Inhibitors
10/21/2010US20100267726 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
10/21/2010US20100267722 Novel proline derivatives
10/21/2010US20100267609 Compounds which inhibit beta-secretase activity and methods of use thereof
10/21/2010US20100267596 Method for improving the hydrolysis stability of ionic liquids
1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 404